Latest Diasorin News & Updates
See the latest news and media coverage for Diasorin. We track all announcements, press releases, and industry mentions in real time, all in one place.
Manufacturer of immunodiagnostic and molecular diagnostic systems
diasorin.com- Headquarters
- Saluggia, Italy
- Company type
- Public company
- Number of employees
- 2,500–5,000
Last updated
Latest news about Diasorin
In short: Diasorin expanded its diagnostic portfolio, secured key FDA clearances, and approved its 2025 financial statements with a €1.30 dividend per share.
Company announcements
-
Diasorin approves 2025 financial statements and €1.30 dividend
Shareholders' meeting approves remuneration policy, second section of remuneration report, and new 2026 stock option plan for executives and employees.
-
Diasorin approves consolidated financial statements
The Board of Directors examined and approved the statements at December 31, 2025.
-
Diasorin launches LIAISON NES FLU A/B, RSV & COVID-19 assay
It offers fast, reliable point-of-care testing with <1 minute hands-on time and results in ~15 minutes. Enables confident decisions without workflow burden.
-
Diasorin shares new clinical study on LIAISON MeMed BV test
The study from NewYork-Presbyterian shows 93.8% sensitivity and 94.6% NPV for differentiating bacterial vs. viral infections in ED patients.
Media coverage
-
The market rewards Diasorin after the turning point on the immunodiagnostics division
The pharmaceutical company has appointed Gabriele Allegri as president of the division which is worth 65% of the group's revenue...
-
DiaSorin, the assembly approves the 2025 financial statements and the dividend (detached on 18 May)
The shareholders' meeting of DiaSorin approved the 2025 financial year accounts - closed with a net civilistic profit of 150.15 million euros - and...
-
Milan closes higher: banks and energy push Piazza Affari, Diasorin down
The Milan Stock Exchange closed the session of April 28, 2026 in decidedly positive territory, recording a 0.77% rise. This trend...
-
Stock market: Qiagen's profit warning drags Diasorin into the red (-2.9%)
QuantiFeron collapses, distributed in partnership with Diasorin (Il Sole 24 Ore Radiocor) - Milan, Apr 28 - Qiagen's profit warning (-6.13% a...
Track Diasorin and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Trending companies
Discover what's making headlines across other trending companies.
Pit
Davis AI
Qutwo
DigiPowerX
Penguin Solutions
Sterling Infrastructure
KIOXIA Corporation
Subquadratic
Tibber
IREN
A24
Hitachi Energy
Ouster
Ormat Technologies
Fabrinet
AOI
WidePoint
Filtronic
Mirum Pharmaceuticals
Capstone Green Energy
AXT
POET Technologies
PurpleFire
Profitable Media
Sironax
Aperture Therapeutics
Attentive
Klaviyo
Twilio
Insider One
Zeta Global
Iterable
Braze
Optimove
Bluecore